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acquired special urgency. There is a paucity of modern 
drugs / agents facilitating acquisition, retention, and 
retrieval of information and knowledge. Ayurveda claims 
that several plants, the so-called ‘medhya’ plants, possess such 
activities. Scientific literature is continuously reporting plant 
drugs having neuromodulatory activity. Shankhapushpi (leaf) 
is one of the prime medhya plants of Ayurveda, which may 
be useful for neural regeneration and synaptic plasticity. 
Jataamansi (rhizome) appears to be an excellent candidate 
for a potential inhibitor of acetylcholinesterase (AChE). 
Ashwagandha (root) is another important anti-aging plant.[1]
The polyherbal formulation contains Withania somnifera 
(Ashwagandha), Nardostachys jatamansi (Jatamansi), Rauwolfia 
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ABSTRACT
Objective: To investigate the neuropsychopharmacological effect of a polyherbal formulation (PHF) on the learning 
and memory processes in rats. Materials and Methods: PHF contains Withania somnifera (Ashwagandha), 
Nardostachys jatamansi (Jatamansi), Rauwolfia serpentina (Sarpagandha), Evolvulus alsinoides (Shankhpushpi), 
Asparagus racemosus (Shatavari), Emblica officinalis (Amalki), Mucuna pruriens (Kauch bij extract), Hyoscyamus 
niger (Khurasani Ajmo), Mineral resin (Shilajit), Pearl (Mukta Shukhti Pishti), and coral calcium (Praval pishti). 
Its effect (500 mg / kg, p.o.) on the learning and memory processes was tested. The activity of PHF on memory 
acquisition and retention was studied using passive avoidance learning and elevated plus maze model (EPM) 
in rats. Results: The animals treated with PHF showed a significant decrease in transfer latency as compared 
to the control group in EPM. PHF also produced significant improvement in passive avoidance acquisition and 
memory retrieval, as compared to the controls and reduced the latency to reach the shock free zone (SFZ) 
after 24 hours. Conclusion: The PHF produces significant improvement in passive avoidance acquisition and 
memory retrieval in rats, which needs further investigation.
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serpentina (Sarpagandha), Evolvulus alsinoides (Shankhpushpi), 
Asparagus racemosus (Shatavari), Emblica officinalis (Amalki), 
Mucuna pruriens (Kauch bij extract), Hyoscyamus niger (Khurasani 
Ajmo), Mineral resin (Shilajit), Pearl (Mukta Shukhti Pishti) 
and coral calcium (praval pishti). This formulation has been 
known for its anti-anxiety, anti-stress, adaptogenic, and 
memory enhancing activity.[2] Withania somnifera, Emblica 
officinalis, Asparagus racemosus and shilajit are classified in 
Ayurveda as rasayanas, which are reputed to promote physical 
and mental health, improve the defense mechanisms of the 
body, and enhance longevity. These attributes are similar 
to the modern concept of adaptogenic agents, which are 
known to provide protection to the human physiological 
system against diverse stressors.[3] Evolvulus alsinoids has been 
used traditionally as a brain tonic, sedative, anthelmintic, 
antiepileptic, and against leukoderma.[4] Seeds of M. pruriens 
also possess antioxidant, hypoglycemic, lipid lowering, and 
neuroprotective activities.[5] Nardostachys jatamansi helps to 
promote physical and mental health, augment resistance of 
the body against disease, and has shown potent antioxidant 
activity. It also shows a marked tranquilizing activity, 
as well as, hypotensive, hypolipidemic anti-ischemic, 
anti-arrythmic, hepatoprotective, anticonvulsant, and 
neuroprotective activities.[6]
There is a lack of scientific data regarding the effect of 
PHF on CNS. The present study is, therefore, focused on 
the evaluation of the neuropsychopharmacological activity 
of PHF in rats.
MATERIALS AND METHODS
Animals
Albino rats weighing between 200 and 250 g were kept 
in groups of four and housed in polypropylene cages, 
in air-conditioned rooms (25 – 28°C), under a standard 
light / dark cycle. The rats were fed with a standard pellet 
diet (Pranav Agro Seeds, Vadodara) and water ad libitum. 
The animals were kept for seven days in a laboratory for 
habituation. The animals were maintained in standard 
environmental conditions and fed with standard diet and 
water. The animals were divided into four groups: Control 
(10 ml/kg saline, orally), Piracetam treated (100 mg/kg), 
Diazepam treated (2.0 mg/kg).
Ethical clearance
All studies were carried out in accordance with the 
guidelines provided by the Indian Council for Medical 
Research and the Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA), 
New Delhi, India. Moreover, the Institutional Animal 
Ethical Committee of the Shri Sarvajanik Pharmacy 
College, Mehsana, approved the study.
Drugs
Piracetam was received as a gift sample from Torrent 
Pharmaceuticals Ltd., Indrad, Gujarat, India, The 
Polyherbal Formulation (PHF) was received as a gift sample 
from Tonix Healthcare, Ahmedabad, India. Diazepam 
(Calmpose) was purchased from the local market. PHF 
contains Withania somnifera (Ashwagandha), Nardostachys 
jatamansi (Jatamansi), Rauwolfia serpentina (Sarpagandha), 
Evolvulus alsinoides (Shankhpushpi), Asparagus racemosus 
(Shatavari), Emblica officinalis (Amalki), Mucuna pruriens (Kauch 
bij extract), Hyoscyamus niger (Khurasani Ajmo), Mineral resin 
(Shilajit), Pearl (Mukta Shukhti Pishti), and coral calcium 
(praval pishti). PHF powder was suspended in distilled water 
and administered orally. 
Preliminary acute toxicity test
Healthy adult male Wistar rats (150 – 200 g) were subjected 
to acute toxicity studies as per the guidelines (AOT 425) 
suggested by the Organization for Economic Cooperation 
and Development (OECD-2000). The rats were observed 
continuously for eight hours, for behavioral and autonomic 
profiles and for any sign of toxicity or mortality, up to a 
period of 14 days.[7]
General pharmacological observation
Behavioral effects of the PHF extract (500 mg / kg) were 
assessed by the method described by Irwin et al., (1968). 
The rats were treated with PHF extract 500 mg / kg. 
The animals were then placed in an observation cage and 
observed after 30 minutes of administration up to two 
hours, for behavioral changes. The observation parameters 
consisted of body position, locomotion, rearing, righting 
reflex, lacrimation, alertness, and reactivity to touch   
stimuli.[8]
Effect on locomotor activity
Locomotor activity was recorded by using a digital activity 
cage (Actophotometer Space-lab, India). Three groups 
of animals were used (n = 6). Each rat was individually 
placed in the actophotometer for five minutes. Two 
groups of animals were orally treated with the saline and 
PHF extract (500 mg/kg). After 60 minutes the rats were 
placed individually in the actophotometer for recording 
the basal activity score. Group III received reference 
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RESULTS
Preliminary acute toxicity test
All the rats were free of any toxicity up to the dose of 2 g 
/ kg, without any mortality. From this data, the 500 mg / 
kg dose of PHF was selected for further study.
General pharmacological observation
The rats that were orally treated with the PHF extract (500 
mg / kg) and submitted to the general observations did 
not show any difference in their behavior and parameters 
determined during the observation periods. They were 
alert, with normal grooming, touch response, and pain 
response. Alertness, limb tone, and grip strength were 
normal and the animals did not show staggering gait or 
contractions.
Effect on locomotor activity
The PHF (500 mg / kg) did not produce any significant 
reduction in locomotor activity when compared with the 
control animals. However, the diazepam-treated group 
showed a statistically significant decrease in locomotor 
activity when compared with the control group [Table 1].
Passive avoidance learning and memory
The transfer latency to reach the shock free zone on the 
seventh day was not significantly changed in both the 
treatment groups as compared to the first day. However, 
the number of mistakes in 15 minutes were significantly 
decreased in the Piracetam-treated group (from 3.125 ± 
0.76 to 1.0 ± 0.26, P < 0.05) and the PHF-treated group 
(from 5.37 ± 0.67 to 3.25 ± 0.41, P < 0.01) at the seventh-
day interval. Similarly transfer latency for acquisition and 
retention was not significantly altered in both the treatment 
groups at the end of 24 hours [Tables 2 and 3, Figures 1 
and 2].
Elevated plus maze
There was no significant change in the number of 
preferences for the open arm in all the three groups 
standard diazepam at a dose of 2.0 mg / kg (i.p.) 30 minutes 
before the test. Mean change in the locomotor activity was 
recorded for each group.[9]
Passive avoidance learning[10]
The apparatus consisted of an electric grid (35 x 35 x 12 
cm) with a wooden piece (8 x 5 x 1 inches) as a shock free 
zone (SFZ) in the center and the entire grid had a perplexed 
enclosure. Each rat was placed individually on the electric 
grid and was allowed to explore the apparatus for about 
one minute. The start button was pressed after selecting 
the proper voltage of current (20 V) for foot shock. The 
start button was kept pressed till the animal reached the 
centrally located shock free zone (SFZ). The latency (in 
seconds) and number of mistakes that the animal made 
in 15 minutes was noted. The animal that took more than 
two minutes to reach the SFZ was rejected. The animal 
was put back on the electric grid and the procedure was 
repeated to get at least three basal readings so that the 
animal got acquainted with the task (trained). The latency 
of the control animals in reaching the SFZ and the number 
of mistakes in 15 minutes were compared with those of 
the treated animals. 
Elevated plus-maze test[11]
The elevated plus-maze consisted of two open (50 x 10 cm) 
and two closed arms (50 x 10 x 40 cm) for rats facing each 
other, with an open roof. A fine white line was drawn in 
the middle of the floor of each enclosed arm. The entire 
maze was elevated at a height of 50 cm for the rats. The 
animals were placed individually at the end of either of the 
open arms and the time the animal took to move from the 
open to the enclosed arm (transfer latency) was noted on 
the first day. Transfer latency (TL) was the elapsed time 
between the time the animal is placed in the open arm and 
the time at which all its legs have crossed the white line, 
into the enclosed arm. The animal was allowed to move 
freely to explore the apparatus for at least 20 seconds. The 
drugs were administered at least 15 – 30 minutes prior to 
the first trial. The transfer latency was again recorded 24 
hours later. If the animals did not enter the enclosed arm 
within 60 seconds on the second trial, TL was assigned as 60 
seconds. Transfer latency measured on the first and second 
days served as parameters for acquisition and retrieval, 
respectively. Each animal was used only once. 
Statistical analysis
The observations are reported as mean ± SEM. The 
statistical analysis was carried out using two-tailed Student’s 
paired t-test. P values < 0.05 were considered as significant.
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Table 1: Effect of PHF and Diazepam on locomotor 
activity in rats
Treatment Mean change in locomotor activity
Saline (1 ml / kg) 25.8 ± 3.14
PHF (500 mg / kg) 30.5 ± 5.25
Diazepam (2 mg / kg) 80.7 ± 3.82*
n = 6, Values are each in mean ± S.E.M.*indicates P < 0.05 (Two tailed Student’s 
paired t-test).122   Journal of Young Pharmacists Vol 3 / No 2
Shah and Goyal: Effects of PHF on learning and memory process in rats
Table 2: Effect on passive avoidance learning and 
memory effects in rats
Treatment (mg / kg) n TL+ in 
seconds
No. of mistakes in 15 
minutes (mean ± SEM)
Saline, 1 ml, first day 
Saline, 1 ml, seventh day
6
6
30.87 ± 4.12
22.37 ± 4.35
5.12 ± 0.97 
4.37 ± 0.82
Piracetam, 100, first day
Piracetam, 100, seventh day
6
6
26.37 ± 6.58
9.37 ± 3.79
3.12 ± 0.76
1.0 ± 0.26* 
PHF, 500, first day
PHF, 500, seventh day
6
6
29 ± 7.25
17.66 ± 4.03
5.37 ± 0.67
3.25 ± 0.41**
+TL: Latency to reach shock free zone, Values are each in mean ± S.E.M. *indicates 
P < 0.05, **indicates P < 0.01, when compared to day one values (Two tailed 
Student’s paired t-test)
Table 3: Effect on transfer latency in passive avoidance 
requisition and retention model in rats
Treatment  
(mg / kg)
n Transfer latency (in seconds) measured 
after
1 hour 24 hours
Saline 6 30.87 ± 4.12 26.75 ± 4.58
Piracetam, 100 6 26.37 ± 6.58 23.62 ± 5.53
PHF, 500 6 29 ± 7.25 26.33 ± 6.82
Figure 1: Effect on transfer latency at the end of 24 hours in passive 
avoidance learning and memory model in rats
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Figure 2: Effect on the number of mistakes in 15 minutes in passive 
avoidance learning and memory model in rats
No. of mistakes
0
1
2
3
4
5
6
7
Saline Piracetam PHF
Groups
N
o
.
o
f
m
i
s
t
a
k
e
s
1st day
7th day
*
**
between the first day and seventh day interval. The number 
of open arm entries were not significantly changed in the 
saline-treated and Piracetam-treated group, but a significant 
fall from 4.5 ± 0.55 to 2.25 ± 0.52 was observed in the 
PHF-treated group (P < 0.05) [Table 4].
Time spent in the open arm in five minutes was not 
significantly changed at the end of the seventh day in the 
treatment groups, whereas, the total number of entries 
decreased significantly in the Piracetam-treated group 
(from 41.75 ± 4.5 to 19.25 ± 2.01, P < 0.001) and in the 
PHF-treated group (from 31 ± 3.13 to 14.87 ± 0.9) P < 
0.001) at the end of the seventh day [Table 4]. 
Also transfer latency after 24 hours was significantly 
decreased in the Piracetam-treated group (from 72.66 ± 
17.09 to 31.66 ± 4.59, P < 0.05) and in PHF-treated group 
(from 74.66 ± 6.64 to 35.22 ± 5.03, P < 0.001) [Table 5].
DISCUSSION
Nootropics represent a new class of psychotropic agents 
with a selective facilitatory effect on the integrative 
functions of the central nervous system, particularly on 
intellectual performance, learning capacity, and memory.[12] 
A number of drugs like Piracetam and Mentat have now 
been introduced and used in therapy to ameliorate cognitive 
deficits.[13] PHF is a polyherbal formulation comprising 
of selective herbs that have proven memory enhancing   
action.[14] 
Locomotor activity is considered as an index of alertness 
and a decrease in it is indicative of sedative activity.[15] 
However, none of the doses of PHF extract were found 
to have any effect on the locomotor activity. Moreover, 
the lack of effect on the locomotor activity worked to the 
advantage of the plant demonstrating nootropic activity. 
The Elevated Plus Maze (EPM) is a commonly used 
method to evaluate the anxiety state in animals, however, 
recent studies of several nootropics and amnesic agents on 
EPM made this model a widely accepted paradigm to study 
the learning and memory process in rodents.[16] It is simple, 
less time consuming, and does not involve the use of any 
sophisticated equipment or prior training.[17] In the EPM, 
acquisition (learning) can be considered as transfer latency 
on the first-day trials and the retention/consolidation 
(memory) is examined 24 hours later. The animals treated Journal of Young Pharmacists Vol 3 / No 2  123
with PHF (500 mg / kg) showed a significant decrease in 
transfer latency as compared to the control group, which 
is an indication of the cognitive enhancer effect of PHF in 
rats.[18] Chronic administration of Piracetam (100 mg / kg) 
and PHF (500 mg / kg) for seven days reduced the number 
of open arm entries, time spent in the open arm, and the 
total number of entries on the seventh day, as compared 
to the first day treatment. 
The passive avoidance test demonstrates the paradigm 
of short-term memory and is usually supplemented with 
the elevated plus maze test.[10] PHF produced significant 
improvement in passive avoidance acquisition and memory 
retrieval, as compared to the control. The memory 
improving the effect of PHF manifested as a decrease in 
latency to reach the Shock Free Zone (SFZ) (acquisition), 
and a significant decrease in the number of mistakes 
(descents) the animal made in 15 minutes (retention) on 
the passive avoidance paradigm. The drug also reduced 
the latency to reach SFZ after 24 hours. These studies 
suggested an effectiveness of PHF in improving short-
term memory in rats. 
Learning the passive avoidance task is known to be 
processed by the cholinergic synapse.[19] PHF might have 
produced improvement in passive avoidance acquisition 
and memory retrieval by the involvement of cholinergic 
mechanisms or by the GABA receptor inhibition improving 
short-term memory in rats.[20] Also a modulatory role of 
the cholinergic or dopaminergic system or 5-HT receptors 
might be speculated in the efficacious role of PHF in 
improving short-term memory in the elevated plus maze 
test.[21]
CONCLUSION
From the findings of the present study it can be concluded 
that PHF produces significant improvement in passive 
avoidance acquisition and memory retrieval in rats. This 
may be due to the involvement of cholinergic mechanisms 
or by the GABA receptor inhibition improving short-
term memory in rats. These findings have scientifically 
validated the traditional claim and suggested its valuable 
role in the treatment of impaired memory functions. The 
study further reveals that the formulation is devoid of any 
neurotoxicity or CNS-depressant effect. As the present 
study is based on the behavioral models without any 
associated neurochemical estimations, it becomes necessary 
to carry out specific binding studies and estimations of 
the neurotransmitter levels in the brain, to understand the 
exact mechanism of action and extend these results further. 
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